You are here

Article info

Article menu
Download PDFPDF
Drug therapy
Editorial
Ethics bureaucracy: a significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases

Authors

  1. Correspondence to Mats G Hansson, Centre for Research Ethics and Bioethics, Department of Public Health and Caring Sciences, Uppsala University, PO Box 564, SE-751 22 Uppsala, Sweden; Mats.Hansson{at}crb.uu.se
View Full Text

Citation

Hansson MG, Gattorno M, Forsberg JS, et al
Ethics bureaucracy: a significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases
Archives of Disease in Childhood 2012;97:561-563.

Publication history

  • Received October 11, 2011
  • Accepted January 12, 2012
  • First published February 22, 2012.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions